Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02607553
Title Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors GenSpera, Inc.
Indications

clear cell renal cell carcinoma

Therapies

Mipsagargin

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Texas Health Science Center, Houston Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field